Let7c and AKT1/AKT2 mRNA balance is different In IPF BAL cells compared to other fibrotic ILDs.

E. Tsitoura (Herakleion, Greece), E. Bibaki (Herakleion, Greece), E. Vasarmidi (Herakleion, Greece), A. Trachalaki (Herakleion, Greece), C. Koutoulaki (Herakleion, Greece), G. Margaritopoulos (London, United Kingdom), K. Karagiannis (Herakleion, Greece), A. Proklou (Herakleion, Greece), D. Moraitaki (Herakleion, Greece), N. Tzanakis (Herakleion, Greece), A. Wells (London, United Kingdom), K. Antoniou (Herakleion, Greece)

Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Disease area: Interstitial lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Tsitoura (Herakleion, Greece), E. Bibaki (Herakleion, Greece), E. Vasarmidi (Herakleion, Greece), A. Trachalaki (Herakleion, Greece), C. Koutoulaki (Herakleion, Greece), G. Margaritopoulos (London, United Kingdom), K. Karagiannis (Herakleion, Greece), A. Proklou (Herakleion, Greece), D. Moraitaki (Herakleion, Greece), N. Tzanakis (Herakleion, Greece), A. Wells (London, United Kingdom), K. Antoniou (Herakleion, Greece). Let7c and AKT1/AKT2 mRNA balance is different In IPF BAL cells compared to other fibrotic ILDs.. 3719

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
BAL protein profiles specific of different interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012

BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012


Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007

The relative expression of genes for arginine transporters in alveolar macrophages from BAL of non specific interstitial pneumonia patients (NSIP)
Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation
Year: 2007


Expression of mRNA of selected inflammatory markers in BALf cells from patients with sarcoidosis and idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017

Stress protein expression in lung fibroblasts and BAL cells in COPD patients and healthy subjects.
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Levels of oxidised mitochondria in BAL macrophages in fibrotic ILDs.
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020


Mechanisms of impaired immune surveillance in lower airways of smokers. Data from bronchoalveolar lavage (BAL) harvested in selected interstitial lung diseases (ILDs) and control group
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


The expression of the chemokine receptors CXCCR3 and CCR4 on T cells reflects the Th2 switch in the bronchoalveolar lavage (BAL) of idiopathic pulmonary fibrosis (IPF) patients
Source: Annual Congress 2004 - Pathobiological and clinical investigations in interstitial lung diseases
Year: 2004


HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008

Collagen1a1 mRNA expression in BAL cells is associated with disease progression and poor survival in ILDs
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020


The expression of miR185, miR29a and their targets in IPF and lung cancer (LC). A BALF study.
Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways
Year: 2017



A comparison of T lymphocytes (TLs) subpopulations in lung tissue and in bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2004; 24: Suppl. 48, 43s
Year: 2004

Differential gene expression of lung fibroblasts derived from UIP and NSIP patterns of interstitial lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 478s
Year: 2002

Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006


Upregulation of expression of membrane apoptosis signals by bronchoalveolar lavage cells in patients with pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002

Differential expression of telomerase activity in patients with autoimmune pulmonary fibrosis in BALF
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010


LSC - 2018 - AKT1/AKT2 mRNA Balance Is Significantly Different In IPF BAL Cells Compared To Other Fibrotic ILDs.
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018



Increased BALF eosinophils and underlying interstitial lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005

PD-L1 expression on alveolar macrophages and in plasma of IPF patients – original research
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018